SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial

Long-term effects, safety and tolerability of oral semaglutide (SEMA; a GLP-1 receptor agonist [GLP-1RA]) vs sitagliptin (SITA) as add-on to metformin ± sulfonylurea was investigated in patients (pts) with T2D in a 78-week, double-blind, double-dummy trial. Pts were randomized to once daily oral SEM...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Rosenstock, Julio, Allison, Dale, Birkenfeld, Andreas, Blicher, Thalia, Deenadayalan, Srikanth, Jacobsen, Jacob, Serusclat, Pierre, Violante, Rafael, Watada, Hirotaka, Davies, Melanie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2019
Soggetti:
Diabetes Mellitus and Glucose Metabolism
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552181/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-139
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi